Samir Mitragotri

YourBio Health, Inc. develops health monitoring products. It is developing an array of products based on the company's proprietary TAP? (Touch Activated Phlebotomy) painless blood collection platform. The company was founded by Richard Rox Anderson, Joerg Lahann, Robert S. Langer Jr., Douglas A. Levinson and Samir Mitragotri in 2008 and is headquartered in Medford, MA.

Skincential Sciences, Inc. is engaged in skin care industry. Its products include refining pen and resurfacing gel. The company was founded by Samir Mitragotri and Russ Lebovitz and is headquartered in San Francisco, CA.

Entrega, Inc. develops oral drug delivery technologies. The firm’s platform enables novel applications in a variety of fields, such as disease management and tracking in the burgeoning mobile health arena. Its proprietary technology seeks to solve the oral delivery problem with an engineering solution that protects the payload and delivers biological molecules, drug substances and nanoparticles. The company was founded by Samir Mitragotri in 2010 and is headquartered in Boston, MA.

fqubed, Inc. develops skin therapeutics. The company also develops innovative soft materials that control the barrier properties of skin in pharmaceutical personal care products. It was founded by John M. Newsam and Lane Logan in 2002 and is headquartered in San Diego, CA.

Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York.

Droplette, Inc. develops transdermal delivery system for delivery of drugs. Its device delivers large molecules deep through skin by utilizing a fluid physics phenomenon. The company was founded by Madhavi Gavini and Rathi Srinivas in 2017 and is headquartered in Boston, MA.

Fount Bio, Inc. is a life science company that develops medical and beauty applications. The company is based in Cambridge, MA. Fount Bio was founded by Samir Mitragotri, Doug A. Levinson. Doug A. Levinson has been the CEO since incorporation.

HitchBio, Inc. develops solutions based on red blood cell transfusion.